"L’Hesperia Hospital Modena è un Ospedale Privato polispecialistico accreditato con il Sistema Sanitario Nazionale e certificato ISO 9001-2008 dal 1999. È dotato di tutte le più attuali apparecchiature di diagnostica e di terapia e un comparto operatorio con sette sale di cui 3 dedicate alla Cardiochirurgia e 2 Laboratori di Emodinamica e di Elettrofisiologia. Ha un’organizzazione dipartimentale, i medici responsabili delle singole Unità e dei Servizi sono specialisti con esperienza pluridecennale nel settore specifico. L’Ospedale è convenzionato con primarie compagnie Assicurative, Fondi e Casse di assistenza."

During the past decade, Hesperia Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hesperia Hospital" #1 sponsor was "A. Manzoni Hospital" with 1 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Edwards Lifesciences" with 1 trials sponsored, "HealthCore-NERI" with 1 trials sponsored and "Medtronic Endovascular" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hesperia Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Besins Healthcare" with 1 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Royal Brompton & Harefield NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hesperia Hospital" are "Androgen Deficiency" (1 trials), "Coronary Arteriosclerosis" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Artery Restenosis" (1 trials) and "Coronary Artery Stenosis" (1 trials). Many other conditions were trialed in "Hesperia Hospital" in a lesser frequency.

Most popular intervention types in "Hesperia Hospital" are "Device" (4 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abre venous self-expanding stent system" (1 trials), "Coronary Angioplasty (PTCA)" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials) and "Epirubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hesperia Hospital" are 5 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hesperia Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hesperia Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hesperia Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".